Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filanesib in Advanced Myeloid Leukemia
NCT00637052Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2008
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of filanesib in acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), sponsored by Pfizer. Started Mar 2008; status: completed.
02
Drugs
filanesib
03
Conditions
acute myeloid leukemia (AML)myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on NCT00637052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637052.